Is the honeymoon over already?
All markets took the proverbial beating last week! What's worse is I don’t believe it is over yet. Volume picked up on all exchanges last week.
All markets took the proverbial beating last week! What's worse is I don’t believe it is over yet. Volume picked up on all exchanges last week.
Today, the markets showed exceptional strength, with a broad-based rally across multiple sectors and robust trading volumes. It’s encouraging to see such widespread participation, indicating strong investor confidence.
Encompass Health (EHC) presents a compelling buy opportunity due to its strong financial performance, positive earnings guidance, and robust market position.
I am selling the stock Affirm (AFRM). I had concerns going into the earnings report when volume spiked negatively, with the stock trading at over twice its average daily volume and declining ahead of earnings.
This is a cautious sell recommendation. I’m concerned about the recent rise in long-term rates, particularly in the 10-year Treasury note, which directly affects 30-year mortgage rates.
Yesterday's rally was part of a relief rally, driven by easing uncertainty, and part Trump rally. Call it what you will, but it was a thunderous move across all exchanges.
Palantir delivered strong earnings, and the aftermarket trading we’re seeing is likely driven by two factors: momentum players and a short squeeze.
All the markets we follow took it on at chin last week, as you'll notice by the charts below. The S&P 500 was down 108 points or 1.85%.
Yesterday, all the markets took a hit as buyers disappeared into the close. The seasonal volatility I’ve mentioned over the past several weeks has now arrived. The current volatility is occurring for several reasons, the most notable being the upcoming election.
Affirm Holdings, Inc. (NASDAQ: AFRM) is strategically positioned to capitalize on the explosive growth of the Buy Now, Pay Later (BNPL) market.